Synthesis of Methotrexate Polyglutamates by Bone Marrow Cells from Patients with Leukemia and Lymphoma
Developmental Pharmacology and Therapeutics · 2019
DOI: 10.1159/000455520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Pharmacology and Therapeutics, 2019. Verfasst von Anne Witte und 3 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref).
Abstract (Originalsprache)
Bone marrow cells from children with lymphoblastic leukemia, myeloblastic leukemia and non-Hodgkin's lyrnphorna wcre incubated with tritium-labelled methotrexate in short-term cultures. Cells obtained both during disease activity as weil as during remission synthesized large quantities of methotrexate polyglutamatcs. Synthesis was time- and dose-dependent and occurred with concentrations of methotrexate regularly achicved during conventional treatment with this drug.
Zitieren
APA
Witte, A., Whitehead, V. M., Rosenblatt, D. S., & Vuchich, M. (2019). Synthesis of Methotrexate Polyglutamates by Bone Marrow Cells from Patients with Leukemia and Lymphoma. Developmental Pharmacology and Therapeutics. https://doi.org/10.1159/000455520
Vancouver
Witte A, Whitehead VM, Rosenblatt DS, Vuchich M. Synthesis of Methotrexate Polyglutamates by Bone Marrow Cells from Patients with Leukemia and Lymphoma. Developmental Pharmacology and Therapeutics. 2019. doi:10.1159/000455520
BibTeX
@article{Witte2019,
author = {Witte, Anne and Whitehead, V. Michael and Rosenblatt, David S. and Vuchich, Mary-Jane},
title = {Synthesis of Methotrexate Polyglutamates by Bone Marrow Cells from Patients with Leukemia and Lymphoma},
journal = {Developmental Pharmacology and Therapeutics},
year = {2019},
doi = {10.1159/000455520}
}
EUVIMED